Call: 1-800-887-8100

 

New here?
Please register
Already a member?
Sign in now

 
Starting COPAXONE(R) Choosing a Therapy Importance of Therapy Therapy Expectations
Share Print

The Importance of Therapy


Video Title Why I Changed to COPAXONE®
Michelle, on COPAXONE® for RRMS since 2002
The Importance of Therapy
Dr. Thrower

Starting treatment as early as possible is one of the best ways to manage your relapsing-remitting multiple sclerosis.1 If left untreated, MS can worsen over time. A study of nerve damage found that even in the early stages of the disease, there is evidence of permanent damage.2

MS may even be active when you are not having symptoms. Early and continued treatment with an approved MS therapy can reduce relapses (worsening or new symptoms) and may help reduce new damage.1

National Multiple Sclerosis Society (NMSS) recommendations1

  • The NMSS recommends that you consider starting therapy as soon as a positive MS diagnosis has been made, or after a first attack for those at high risk of MS
  • Early relapses—even those that are seemingly benign—may cause permanent damage, reinforcing the importance of early treatment
  • Stay with your treatment for the long term unless your therapy causes intolerable side effects or shows a clear lack of benefit

Talk to your doctor to see if COPAXONE® is the right therapy for you.



Current rating: 3.7 (15 ratings)

References:
1. Disease management consensus statement. National Multiple Sclerosis Society Web site. http://www.nationalmssociety.org/download.aspx?id=8. Accessed June 22, 2010. 2. Trapp BD, Peterson J, Ransohoff RM, et al. N Engl J Med. 1998;338(5):278-285.
COP100006112/101808
  • COPAXONE® (glatiramer acetate injection) is indicated for the reduction of the frequency of relapses in relapsing-remitting multiple sclerosis, including patients who have experienced a first clinical episode and have MRI features consistent with multiple sclerosis.

Important Safety Information About COPAXONE®

  • The most common side effects of COPAXONE® are redness, pain, swelling, itching, or a lump at the site of injection, flushing, rash, shortness of breath, and chest pain. These reactions are usually mild and seldom require professional treatment. Be sure to tell your doctor about any side effects.

    Some patients report a short-term reaction right after injecting COPAXONE®. This reaction can involve flushing (feeling of warmth and/or redness), chest tightness or pain with heart palpitations, anxiety, and trouble breathing. These symptoms generally appear within minutes of an injection, last about 15 minutes, and go away by themselves without further problems.

    A permanent indentation under the skin at the injection site may occur, due to a local destruction of fat tissue. Be sure to follow proper injection technique and inform your doctor of any skin changes.

    After you inject COPAXONE®, call your doctor right away if you develop hives, skin rash with irritation, dizziness, sweating, chest pain, trouble breathing, severe pain at the injection site or other uncomfortable changes in your general health. Do not give yourself any more injections until your doctor tells you to begin again.

    You are encouraged to report negative side effects of prescription drugs to the FDA. Visit www.fda.gov/medwatch, or call 1-800-FDA-1088.

#1 Prescribed RRMS therapy in the US*

Suggested articles

Benefits & Insurance Assistance

COPAXONE Co-pay Solutions™

Therapy and Immune Health

10 Tips for CarePartners

Choosing a Therapy

Your MS Online Planner


My recent articles

Therapy Expectations

Choosing a Therapy

MS Tips & Experiences

Starting COPAXONE®

master_PDF.png  Download Adobe Acrobat
*IMS Health National Prescription Audit, May 2011. Data is proprietary to IMS Health.
 

COPAXONE® is a registered trademark of Teva Pharmaceutical Industries Ltd. Shared Solutions® is a registered trademark of Teva Neuroscience, Inc. autoject® 2 for glass syringe is a registered trademark of Owen Mumford, Ltd. COPAXONE CO-PAY SOLUTIONS™ is a trademark of Teva Pharmaceutical Industries Ltd. © 2011, Teva Neuroscience, Inc. All Rights Reserved. This site is intended for US residents only.

The brands listed are the trademarks and registered trademarks of their respective owners.